Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
In a volatile world, a few dominant companies offer steadier upside. This article spotlights two stocks with monster ...
Investors are weighing whether the late micron technology stock still offers upside after a stunning rally. This guid...
Deciding between SOXX and IYW means choosing between a laser focus on chips and a wide tech umbrella. This guide brea...
A Vanguard ETF is delivering eye-popping gains in 2026, outpacing the S&P 500. But how long can this momentum last wh...
Cathie Wood is known for bold bets, but recently her moves hint at bargain-hunting in big-name tech. This article bre...
Meta Platforms faces a heavy AI investment cycle that could weigh on near-term cash flow, even as revenue climbs. Thi...
Tesla is steering its $25 billion capex plan beyond cars and into AI and robotics. This shift could transform margins...
A block production hiccup temporarily paused Base, the Coinbase-backed layer-2 on Ethereum. This article breaks down ...
Florida’s housing boom faces a growing threat: AI-enabled deed and title fraud. This report outlines the risks and pr...
Standard Chartered reaffirms a lofty Bitcoin target as Trump underscores China risk, pointing to crypto sovereignty a...